Related Experiment Video
Updated: Jul 26, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
[Serum uric acid--a cardiovasular risk factor?].
1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. alderman@aecom.yu.edu
Therapeutische Umschau. Revue Therapeutique
|October 21, 2004
Summary
Elevated serum uric acid is a significant risk factor for cardiovascular and renal diseases. Reducing uric acid levels may offer cardioprotective benefits, warranting further clinical trials in hypertensive patients.
Area of Science:
- Cardiology
- Nephrology
- Metabolic Diseases
Context:
- Serum uric acid is an independent risk factor for cardiovascular and renal diseases in patients with hypertension, heart failure, or diabetes.
- Hyperuricemia is linked to adverse effects on endothelial function, oxidative metabolism, and blood rheology.
Purpose:
- To explore the role of serum uric acid in cardiovascular and renal diseases.
- To investigate the potential cardioprotective effects of reducing uric acid levels.
Summary:
- Elevated serum uric acid predicts mortality in heart failure and coronary artery disease, and cardiovascular events in diabetes.
- Recent findings suggest that decreasing serum uric acid may attenuate cardiovascular risk in hypertensive patients with left ventricular hypertrophy (LVH).
- A losartan-based therapy showed benefits partly attributable to reduced serum uric acid levels compared to atenolol.
Impact:
- Further research, including randomized clinical trials, is needed to confirm the long-term cardioprotective benefits of lowering hyperuricemia in hypertensive individuals.
- Understanding the mechanisms by which uric acid influences cardiovascular disease is crucial for developing targeted therapies.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.